Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · IEX Real-Time Price · USD
0.0400
+0.0027 (7.24%)
At close: Apr 18, 2024, 4:00 PM
0.0426
+0.0026 (6.50%)
Pre-market: Apr 19, 2024, 7:12 AM EDT
Company Description
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States.
It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone.
The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Sintx Technologies, Inc.
| Country | United States |
| Founded | 1996 |
| IPO Date | Feb 13, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 43 |
| CEO | Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D. |
Contact Details
Address: 1885 West 2100 Street Salt Lake City, Utah 84119 United States | |
| Phone | 801-839-3516 |
| Website | sintx.com |
Stock Details
| Ticker Symbol | SINT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001269026 |
| CUSIP Number | 829392307 |
| ISIN Number | US8293926049 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D. | Chief Executive Officer, President, Principal Financial Officer and Chairman |
| David Francis O'Brien | Executive Vice President and Chief Operating Officer |
| Michael Marcroft | Vice President of Sales and Marketing |
| Gina Moss | Director of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 16, 2024 | DEFN14A | Filing |
| Apr 12, 2024 | 8-K | Current Report |
| Apr 5, 2024 | PRE 14A | Other preliminary proxy statements |
| Apr 4, 2024 | 8-K | Current Report |
| Apr 4, 2024 | 424B5 | Filing |
| Apr 1, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Mar 29, 2024 | 424B5 | Filing |
| Mar 27, 2024 | 10-K | Annual Report |
| Mar 26, 2024 | 8-K | Current Report |
| Mar 26, 2024 | 424B5 | Filing |